Form 4: Nutex Health Executive Warren Hosseinion Reports Stock Transactions

Warren Hosseinion, President of Nutex Health, Inc., reports the vesting and subsequent sale of shares to cover tax obligations.

Summary

• On March 1, 2025, Warren Hosseinion, President of Nutex Health, Inc., reported transactions involving common stock and restricted stock units (RSUs).
• 3,776 shares of common stock were acquired upon the vesting of RSUs.
• 1,072 shares were sold on April 4, 2025, at a price of $72.0972 to cover tax withholding obligations.
• Following these transactions, Hosseinion directly owns 3,422 shares of common stock.
• Hosseinion also holds 15,102 derivative securities in the form of Restricted Stock Units.
• The RSUs vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not convey any particularly positive or negative sentiment. It simply reports transactions.

Future Outlook

The document outlines the vesting schedule for the remaining RSUs held by Warren Hosseinion, which will occur in equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It is standard practice for executives to sell shares to cover tax obligations arising from the vesting of stock awards.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The vesting schedule of the RSUs is typical, with vesting occurring over a period of several years to incentivize long-term performance.
• Selling shares to cover tax obligations is a common practice among executives receiving stock-based compensation.

Key Dates

Keywords

Nutex Health, Warren Hosseinion, Form 4, Stock Transactions, Restricted Stock Units, Beneficial Ownership, Insider Trading